
NASDAQHealthcareBiotechnology
最新資料
US$2.80
−US$0.13 · -4.44%
Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
前收盤價
US$2.80
−US$0.13 · -4.44%
盤中時間採用ET。市場資料可能有所延遲。
Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
日內區間
目前US$2.80
52週區間
目前US$2.80
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | — | 5000 USD | 2500 USD | — | — |
| 銷貨成本 | 5198 USD | — | — | — | — |
| 毛利 | −5198 USD | — | — | — | — |
| 研究與開發 | 160.7萬 USD | 132.94萬 USD | — | — | — |
| 銷售、一般及管理費用 | 183.08萬 USD | 68.35萬 USD | 19.16萬 USD | 2.99億 USD | 30.92萬 USD |
| 營業費用 | 437.1萬 USD | 292.44萬 USD | 31.01萬 USD | 84.8億 USD | 30.9萬 USD |
| 利息支出 | −642 USD | 200 USD | — | −38.2萬 USD | — |
| 折舊和攤銷 | 5198 USD | 5174 USD | — | — | 23.66萬 USD |
| 營業利益 | −437.1萬 USD | −291.94萬 USD | −30.76萬 USD | −84.73億 USD | −30.9萬 USD |
| 淨利 | −400.17萬 USD | −290.13萬 USD | −29.82萬 USD | −84.65億 USD | −26.5萬 USD |
公司資料更新於 2026年11月22日。
近期已公布業績
近期已公布業績
年度分割調整後的每股現金分配。
US$12.50
2022年(完整年度)+38.9% 自從 2020
US$9.00
2,020
US$12.50
2,022
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2022年3月10日 | US$0.25Special | — | — |
股息 | 2020年4月24日 | US$0.18Special | — | — |
除息 2022年3月10日
US$0.25
Special
除息 2020年4月24日
US$0.18
Special
AI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。